← Holders
Propel Bio Management, LLC
What Propel Bio Management, LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1969764 · Filed Nov 13, 2026
- Positions
- 30
- Reported value
- $188.6M
- Opened
- 6
- Closed
- 5
- Other managers included
- 1
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$99.9M16 positions
- Dec 31, 2025$117.1M20 positions
- Mar 31, 2026$158.7M38 positions
- Jun 30, 2026$191.1M29 positions
- Sep 30, 2026$188.6M30 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
PAGPPlains GP Holdings LP | 1.3M | ±0% | $33M | 17.5% |
ACHVAchieve Life Sciences, Inc. | 3.9M | −4.2% | $31.3M | 16.6% |
DCTHDelcath Systems, Inc. | 604.7K | −30.6% | $9.7M | 5.1% |
COLLCollegium Pharmaceutical, Inc | 410.2K | New | $9M | 4.7% |
CORTCorcept Therapeutics Inc | 75.3K | −44.9% | $8.7M | 4.6% |
AQSTAquestive Therapeutics, Inc. | 278.7K | −80.7% | $8.6M | 4.6% |
MISTMilestone Pharmaceuticals Inc. | 9.4M | +27.2% | $8.2M | 4.3% |
PHATPhathom Pharmaceuticals, Inc. | 1.1M | +5.3% | $8.1M | 4.3% |
CMPSCOMPASS Pathways plc | 549.2K | New | $6.8M | 3.6% |
OBIOOrchestra BioMed Holdings, Inc. | 896.7K | ±0% | $5.6M | 3% |
MAZEMaze Therapeutics, Inc. | 192K | +338.4% | $5.2M | 2.8% |
ABEOAbeona Therapeutics Inc. | 956K | −2.8% | $5M | 2.7% |
ARTVArtiva Biotherapeutics, Inc. | 696.4K | ±0% | $5M | 2.6% |
KYTXKyverna Therapeutics, Inc. | 700.6K | −20.7% | $4.8M | 2.5% |
IVAInventiva S.A. | 1.1M | −11.5% | $4.2M | 2.2% |
CABACabaletta Bio, Inc. | 2M | New | $3.9M | 2.1% |
SABSSAB Biotherapeutics, Inc. | 1.2M | +10.3% | $3.8M | 2% |
PROKProkidney Corp. | 2M | New | $3.3M | 1.8% |
CRVSCorvus Pharmaceuticals, Inc. | 264.3K | +275.5% | $3M | 1.6% |
PALIPalisade Bio, Inc. | 2.2M | −13.9% | $3M | 1.6% |
OCULOcular Therapeutix, Inc | 358K | ±0% | $2.7M | 1.5% |
SCYXScynexis Inc | 541.5K | −0.4% | $2.7M | 1.4% |
FDMT4D Molecular Therapeutics, Inc. | 179.2K | −29.1% | $2.6M | 1.4% |
OVIDOvid Therapeutics Inc. | 1M | −8.7% | $2.5M | 1.3% |
IMUXImmunic, Inc. | 236.7K | −27.2% | $2.2M | 1.2% |
UPBUpstream Bio, Inc. | 335.4K | −4.3% | $1.8M | 0.9% |
IRDOpus Genetics, Inc. | 270K | New | $1.3M | 0.7% |
CLDXCelldex Therapeutics, Inc. | 37.5K | −63.8% | $1.2M | 0.6% |
SGPSpyGlass Pharma, Inc. | 41.4K | New | $1.1M | 0.6% |
LONALeonaBio, Inc. | 149.3K | ±0% | $532.9K | 0.3% |